Patterns of co-association of C-reactive protein and nitric oxide in malaria in endemic areas of Iran

被引:9
作者
Nahrevanian, Hossein [1 ]
Gholizadeh, Jafar [2 ]
Farahmand, Mahin [1 ]
Assmar, Mehdi [1 ]
机构
[1] Pasteur Inst Iran, Dept Parasitol, Tehran 13164, Iran
[2] Hlth Ctr W Azerbaijan Prov, Urumia Lab Educ & Qual Control, Urumia, Iran
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 2008年 / 103卷 / 01期
关键词
C-reactive protein; Iran; nitric oxide; malaria; Plasmodium;
D O I
10.1590/S0074-02762008000100006
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
In addition to numerous immune factors, C- reactive protein ( CRP) and nitric oxide ( NO) are believed to be molecules of malaria immunopathology. The objective of this study was to detect CRP and NO inductions by agglutination latex test and Griess microassay respectively in both control and malaria groups from endemic areas of Iran, including Southeastern ( SE) ( Sistan & Balouchestan, Hormozgan, Kerman) and Northwestern ( NW) provinces ( Ardabil). The results indicated that CRP and NO are produced in all malaria endemic areas of Iran. In addition, more CRP and NO positive cases were observed amongst malaria patients in comparison with those in control group. A variable co- association of CRP/ NO production were detected between control and malaria groups, which depended upon the malaria endemic areas and the type of plasmodia infection. The percentage of CRP/ NO positive cases was observed to be lower in NW compare to SE region, which may be due to the different type of plasmodium in the NW ( Plasmodium vivax) with SE area ( P. vivax, Plasmodium falciparum, mixed infection). The fluctuations in CRP/ NO induction may be consistent with genetic background of patients. Although, CRP/ NO may play important role in malaria, their actual function and interaction in clinical forms of disease remains unclear.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 36 条
[1]  
Ablij Hans, 2002, Eur J Intern Med, V13, P412, DOI 10.1016/S0953-6205(02)00132-2
[2]  
Assmar Mehdi, 2003, Southeast Asian J Trop Med Public Health, V34 Suppl 2, P15
[3]   Nitric oxide protects against chloroquine resistant Plasmodium yoelii nigeriensis parasites in vitro [J].
Awasthi, A ;
Kumar, A ;
Upadhyay, SN ;
Yamada, T ;
Matsunaga, Y .
EXPERIMENTAL PARASITOLOGY, 2003, 105 (3-4) :184-191
[4]   The effect of nitric oxide on the growth of Plasmodium falciparum, P-chabaudi and P-berghei in vitro [J].
Balmer, P ;
Phillips, HM ;
Maestre, AE ;
McMonagle, FA ;
Phillips, RS .
PARASITE IMMUNOLOGY, 2000, 22 (02) :97-106
[5]   Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions [J].
Becker, K ;
Tilley, L ;
Vennerstrom, JL ;
Roberts, D ;
Rogerson, S ;
Ginsburg, H .
INTERNATIONAL JOURNAL FOR PARASITOLOGY, 2004, 34 (02) :163-189
[6]   Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity [J].
Bogdan, C ;
Röllinghoff, M ;
Diefenbach, A .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :64-76
[7]   Nitric oxide production and nitric oxide synthase activity in malaria-exposed Papua New Guinean children and adults show longitudinal stability and no association with parasitemia [J].
Boutlis, CS ;
Weinberg, JB ;
Baker, J ;
Bockarie, MJ ;
Mgone, CS ;
Cheng, Q ;
Anstey, NM .
INFECTION AND IMMUNITY, 2004, 72 (12) :6932-6938
[8]   Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults [J].
Boutlis, CS ;
Tjitra, E ;
Maniboey, H ;
Misukonis, MA ;
Saunders, JR ;
Suprianto, S ;
Weinberg, JB ;
Anstey, NM .
INFECTION AND IMMUNITY, 2003, 71 (07) :3682-3689
[9]   Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children [J].
Clark, IA ;
Awburn, MM ;
Whitten, RO ;
Harper, CG ;
Liomba, NG ;
Molyneux, ME ;
Taylor, TE .
MALARIA JOURNAL, 2003, 2 (1)
[10]   iNOS promoter variants and severe malaria in Ghanaian children [J].
Cramer, JP ;
Mockenhaupt, FP ;
Ehrhardt, S ;
Burkhardt, J ;
Otchwemah, RN ;
Dietz, E ;
Gellert, S ;
Bienzle, U .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (10) :1074-1080